Mounjaro vs Ozempic: Brands, Devices and Access

A useful comparison starts with the exact prescription and treatment goal. Mounjaro and Ozempic are brand names; tirzepatide and semaglutide are their active ingredients. This page focuses on the practical questions to bring to a clinician or pharmacist. For efficacy results, use our separate clinical trial comparison.

Confirm the product and indication

Question	Mounjaro	Ozempic
Active ingredient	Tirzepatide	Semaglutide
Injection schedule	Weekly	Weekly
Related weight-management brand	Zepbound	Wegovy

The US Mounjaro label includes type 2 diabetes treatment and a cardiovascular-risk indication in eligible adults. Ozempic includes type 2 diabetes treatment and cardiovascular and kidney-risk indications in specified adult populations. The eligibility criteria are not identical. Mounjaro label, Ozempic label

Ask the clinician to name the condition being treated and whether the proposed use matches the exact product's current label. This makes a coverage discussion more concrete and helps distinguish evidence about an ingredient from claims about a particular brand.

Compare the device you will receive

Packaging and instructions can differ between products and markets. Mounjaro's current US label includes single-dose and multiple-dose presentations; Ozempic has its own pen instructions and strengths. Follow the instructions supplied with the dispensed product. Mounjaro instructions, Ozempic instructions

Before leaving the pharmacy, ask for a demonstration and confirm what supplies are included. Explain if you have difficulty reading the label, gripping the device or following the steps. Ask where to get replacement instructions. Do not assume a video for another presentation matches your package.

Get a written cost and coverage answer

Instead of relying on an advertised monthly price, ask your pharmacy and insurer for the terms applying to your prescription:

• Which product, strength and quantity does the quote cover?
• Is prior authorization required, and who submits it?
• What would the refill cost after any temporary discount ends?
• Are visits, supplies or additional services billed separately?
• If the prescription changes, must coverage be checked again?

Keep the quote date and the contact's answer. This is a comparison worksheet, not a current price estimate or a promise of coverage. A saving at the first fill does not answer what ongoing treatment would cost.

Arrange follow-up before making a change

Ask your prescriber what benefit is being monitored, when the next review is due and which side effects require contacting the team. Bring the names and doses of other medicines you take. If supply or cost becomes a problem, contact the prescriber rather than constructing your own switching schedule.

A milligram number on one medicine is not a conversion instruction for another. Use a plan from the prescribing clinician, including what to do about missed doses or an interruption.

Keep research and personal suitability separate

An average trial result can inform a discussion, but it cannot determine your prescription on its own. Our SURPASS-2 and SURMOUNT-5 explainer shows why the study population and tested doses matter. The tirzepatide introduction explains the ingredient and its brands.

Sources checked September 9, 2026: the manufacturer prescribing information linked above. We do not sell or receive a referral commission for these prescription medicines.